Pfizer

US expects 100 million people vaccinated by February

WASHINGTON, United States (AFP) -- The US hopes to have immunized 100 million people against Covid-19 by the end of…

In historic first, UK to introduce Pfizer-BioNTech vaccine next week

by Jitendra JOSHI LONDON, United Kingdom (AFP) -- Britain on Wednesday became the first Western country to approve a Covid-19…

US Operation Warp Speed backed vaccines for whole world

by Ivan Couronne Agence France Presse WASHINGTON, United States (AFP) -- President Donald Trump's announcement in May of plans to…

Best case scenario: COVID vaccines by May or July next year; 25M-30M to be vaccinated yearly

Galvez cites supply-demand challenge; need for ultra cold chain storage, distribution (Eagle News) -- The Philippine COVID-19 czar said that vaccines…

In Brazil, Pfizer begins process to register Covid-19 vaccine

SAO PAULO, Brazil (AFP) -- Pfizer gave the office of Brazil's health regulators results of the tests of their Covid-19…

Pfizer/BioNTech seek first vaccine approval in US

  by Ivan Couronne with Yann Schreiber in Mainz Agence France Presse WASHINGTON, United States (AFP) -- US biotech giant…

What are clinical trials and how do they work?

  by Ivan Couronne Agence France Presse WASHINGTON, United States (AFP) -- To find out whether experimental Covid-19 vaccines are…

Pfizer/BioNTech say results show Covid vaccine 95% effective

by Issam Ahmed WASHINGTON, United States (AFP) -- Pfizer and BioNTech said Wednesday a completed analysis of their experimental Covid-19…

Pfizer ‘very close’ to applying for US emergency approval, says CEO

WASHINGTON, United States (AFP) -- Pfizer is "very close" to applying for an emergency use approval for its Covid-19 vaccine…

Frontrunners emerge in race for Covid-19 vaccine

PARIS, France (AFP) — Dozens of companies, from biotech start-ups to Big Pharma, are racing to develop a safe and…

Covid-19 vaccine ‘best science news’ of 2020

by Nina LARSON Agence France-Presse GENEVA, Switzerland (AFP) — Data indicating that a vaccine being developed against Covid-19 is highly…

Pfizer CEO sold $5.6 million in stock on day of vaccine announcement

WASHINGTON, United States (AGP) -- Pfizer CEO Albert Bourla sold $5.6 million of his stock in the US pharmaceutical company…

This website uses cookies.